Vinculin Monoclonal Antibody (7F9), Biotin, eBioscience and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0349861-V3
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $313.46
About this award
Life Technologies Corporation was awarded contract A207_PO-0349861-V3 by the University of Virginia on October 10, 2026, with a cumulative contract value of $313. The award encompasses the procurement of two specialized life science products: 67 units of MEM (Minimum Essential Medium) nucleosides in 500 milliliter quantities and 245 units of Vinculin Monoclonal Antibody (7F9) conjugated with Biotin from eBioscience. Both line items are priced at $1 per unit and are to be delivered to the University of Virginia as the buyer.
The contract represents a state and local procurement issued in Virginia and supports the University of Virginia's research operations. The relatively modest contract value suggests this represents a routine purchase order for laboratory reagents and antibodies, which are consumable materials essential for molecular and cellular research applications. The University of Virginia serves as both the contracting organization and performance location for this award.
Line items
| Item | Total |
|---|---|
| MEM, nucleosides, 500 mL | $67.00 |
| Vinculin Monoclonal Antibody (7F9), Biotin, eBioscience | $245.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0349861-V3?
Contract A207_PO-0349861-V3 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on October 10, 2026.
How much is contract A207_PO-0349861-V3 worth?
Its cumulative value is $313.46.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award